Skip to content

Efficacy Analysis of Rectal Remnant Length in Laparoscopic Subtotal Colectomy with Isoperistaltic Cecorectal Anastomosis for Slow-Transit Constipation

Efficacy Analysis of Rectal Remnant Length in Laparoscopic Subtotal Colectomy with Isoperistaltic Cecorectal Anastomosis for Slow-Transit Constipation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126671
Enrollment
Unknown
Registered
2026-06-13
Start date
2026-06-15
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Slow transit constipation

Interventions

Short Stump Group:None
Long Stump Group:None

Sponsors

Affiliated hangzhou first people's hospital, zhejiang university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Fulfilled the diagnostic criteria for functional constipation according to the Rome IV criteria; 2.Aged between 18 and 75 years; 3.Experienced severe constipation symptoms that significantly impaired quality of life and work performance; 4.Demonstrated delayed colonic transit on the colonic transit study, with multiple radiopaque markers retained in the colon at 72 hours and a markedly prolonged total colonic transit time, consistent with slow-transit constipation (STC); 5.Failed to achieve satisfactory symptom relief despite long-term conservative treatment, including dietary modification, laxatives, and prokinetic therapy; 6.Had no evidence of organic colorectal disease; 7.Underwent anorectal physiological evaluation showing no abnormalities of pelvic floor muscle function or anorectal reflexes on anorectal manometry. Defecography excluded outlet obstruction-related disorders, including rectocele, rectal mucosal prolapse, enterocele, puborectalis syndrome, paradoxical pelvic floor contraction, and impaired opening of the anorectal angle during defecation; 8.Had no evidence of congenital megacolon or other neuromuscular disorders affecting intestinal motility; 9.Expressed a clear willingness to undergo surgery and provided written informed consent; 10.Were considered suitable candidates for surgery and postoperative follow-up, with no significant psychiatric disorders or severe systemic diseases that could affect treatment outcomes;

Exclusion criteria

Exclusion criteria: 1.Presence of severe systemic diseases that precluded surgical treatment, including severe coronary artery disease, decompensated heart failure, severe diabetic complications, advanced respiratory disease, cerebrovascular disease, or other conditions associated with an unacceptable operative risk; 2.Evidence of obstructed defecation syndrome (ODS) based on anorectal physiological and imaging assessments, including abnormal findings on defecography (e.g., rectocele, excessive perineal descent, hypertrophy of the puborectalis muscle, or deep puborectalis impression) and/or anorectal manometry demonstrating paradoxical contraction of the external anal sphincter or puborectalis muscle during defecation, inadequate propulsive force, or increased sphincter tone; 3.Presence of structural or organic colorectal diseases, including congenital megacolon, colonic stricture, colonic diverticular disease, diverticulitis, colorectal malignancy, benign colonic tumors, adenomas, polyps, inflammatory bowel disease, or other organic colorectal disorders; 4.Severe psychiatric or psychological disorders, such as major depressive disorder or schizophrenia, or any mental condition that could interfere with treatment compliance or postoperative follow-up; 5.Presence of other gastrointestinal motility disorders, including small-bowel dysmotility, delayed gastric emptying, or generalized gastrointestinal motility dysfunction involving multiple segments of the digestive tract; 6.History of major colorectal surgery or abdominal surgery resulting in significant anatomical alterations that could affect surgical planning or postoperative outcomes; 7.Incomplete follow-up data or loss to follow-up after surgery.

Design outcomes

Primary

MeasureTime frame
Wexner Constipation Scale;Wexner Incontinence Score (WIS);

Secondary

MeasureTime frame
Gastrointestinal Quality of Life Index (GIQLI) score;Abdominal pain/bloating frequency scale;Anorectal manometry (RAIR, anal resting pressure, maximum squeeze pressure);Rectal stump length;Operative time;Time to first flatus;Postoperative complications;Hospital stay;Intraoperative blood loss;

Countries

China

Contacts

Public ContactCheng Kangwen

Affiliated hangzhou first people's hospital, zhejiang university school of medicine

chengkangwen0556@sian.com+86 571 6784700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026